Opioid Addiction Treatment Using @entity4783 - XXXX In A Community-Based Internal Medicine Practice.

@entity1 @entity4784 @entity1510 @entity4783
BACKGROUND: Opioid dependency currently affects over 2.5 million @entity1 in the United States and is increasing in incidence. Office-based opioid therapy with @entity4783 - @entity1510 provides greater @entity1 access to treatment and has significantly improved therapeutic outcomes. METHODS: We conducted a study of 100 consecutive @entity1 treated for @entity4784 with @entity4783 - @entity1510 in a single provider's community-based internal medicine practice. The primary outcome measures were retention in therapy, wellness, and abstinence from ongoing drug use. Data were obtained from frequent physical examinations, self-report data, and periodic urine drug screening. RESULTS: The retention rate in therapy was 75%. A multidimensional evaluation of wellness improved in 75% of the @entity1 . Eighty-five percent reported no opiate relapse during therapy. CONCLUSION: Office-based opioid therapy with @entity4783 - @entity1510 has provided greater access to therapy with improved therapeutic outcomes. Our findings support the mounting literature that more @entity1 should be offered office-based opioid therapy for opioid dependency.
